Cargando…

Systemic inflammation and pro-inflammatory cytokine profile predict response to checkpoint inhibitor treatment in NSCLC: a prospective study

Treatment with single agent immune checkpoint inhibitors (ICIs) has tremendously changed second line therapy in NSCLC. However, there are still no reliable biomarkers predicting response and survival in this group of patients. PD-L1 revealed to be a correlating, but no perfect marker. Therefore, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kauffmann-Guerrero, Diego, Kahnert, Kathrin, Kiefl, Rosemarie, Sellmer, Laura, Walter, Julia, Behr, Jürgen, Tufman, Amanda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149421/ https://www.ncbi.nlm.nih.gov/pubmed/34035415 http://dx.doi.org/10.1038/s41598-021-90397-y

Ejemplares similares

Consequences of the COVID-19 pandemic on lung cancer care and patient health in a German lung cancer center: results from a cross-sectional questionnaire
por: Walter, Julia, et al.
Publicado: (2022)

Markers of Immune Cell Exhaustion as Predictor of Survival in Surgically-Treated Early-Stage NSCLC
por: Sellmer, Laura, et al.
Publicado: (2022)

Changes in Behavior After Vaccination and Opinions Toward Mask Wearing: Thoracic Oncology Patient–Reported Experiences During the COVID-19 Pandemic
por: Bolt, Toki, et al.
Publicado: (2022)

Osimertinib rechallenge under steroid protection following osimertinib-induced pneumonitis: three case studies
por: Bickert, Christiane, et al.
Publicado: (2021)

Tumor seeding following CT- guided transthoracic needle biopsy in lung cancer. A case report
por: Melzer, Thomas, et al.
Publicado: (2023)

Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing
por: Kahnert, Kathrin, et al.
Publicado: (2023)

Role of the erythropoietin receptor in Lung Cancer cells: erythropoietin exhibits angiogenic potential
por: Liu, Xiaoqing, et al.
Publicado: (2020)

Frequency and clinical relevance of EGFR mutations and EML4–ALK translocations in octogenarians with non-small cell lung cancer
por: Tufman, Amanda, et al.
Publicado: (2017)

Interleukin-22 is elevated in lavage from patients with lung cancer and other pulmonary diseases
por: Tufman, Amanda, et al.
Publicado: (2016)

Correction to: Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer
por: Kauffmann-Guerrero, Diego, et al.
Publicado: (2021)

Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer
por: Kauffmann-Guerrero, Diego, et al.
Publicado: (2020)

Comparison of the sensitivity of different criteria to select lung cancer patients for screening in a cohort of German patients
por: Walter, Julia, et al.
Publicado: (2023)

Basic Determinants of Disease Knowledge in COPD Patients: Results from COSYCONET
por: Fischer, Carolina, et al.
Publicado: (2022)

Clinical Management and Outcome of Grade III Pneumonitis after Chemoradioimmunotherapy for Inoperable Stage III Non-Small Cell Lung Cancer—A Prospective Longitudinal Assessment
por: Kauffmann-Guerrero, Diego, et al.
Publicado: (2021)

A persistent pneumothorax? 5-year follow-up after diagnosis of Swyer–James–MacLeod syndrome
por: Tufman, Amanda, et al.
Publicado: (2016)

Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice
por: Walter, Julia, et al.
Publicado: (2023)

Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort – Determinants and Consequences
por: Lutter, Johanna I, et al.
Publicado: (2021)

Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition
por: Unterrainer, Marcus, et al.
Publicado: (2021)

Response to high-altitude triggers in seasonal asthmatics on and off inhaled corticosteroid treatment
por: Mertsch, Pontus, et al.
Publicado: (2022)

Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONET
por: Trudzinski, Franziska C., et al.
Publicado: (2022)

(68)Ga-EMP-100 PET/CT—a novel method for non-invasive assessment of c-MET expression in non-small cell lung cancer
por: Unterrainer, Lena M., et al.
Publicado: (2022)

Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis
por: Flörsch, Benedikt, et al.
Publicado: (2022)

The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort
por: von Siemens, Sarah Marietta, et al.
Publicado: (2019)

Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET
por: Kellerer, Christina, et al.
Publicado: (2021)

Novel Multimodal Management of Post-Partum Synchronous Metastatic Pulmonary EBV-Associated Lymphoepithelioma-Like Carcinoma (LELC)—A Case Report
por: Pazos, Montserrat, et al.
Publicado: (2021)

Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severity, lung function decline, and mortality
por: Kahnert, Kathrin, et al.
Publicado: (2023)

Omentin-1 prevents inflammation-induced osteoporosis by downregulating the pro-inflammatory cytokines
por: Rao, Shan-Shan, et al.
Publicado: (2018)

Hyperprogressive NSCLC With Two Immune-Checkpoint Inhibitors
por: Kasparian, Saro, et al.
Publicado: (2020)

Thioredoxin Ameliorates Cutaneous Inflammation by Regulating the Epithelial Production and Release of Pro-Inflammatory Cytokines
por: Tian, Hai, et al.
Publicado: (2013)

Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC
por: Reuss, Joshua E., et al.
Publicado: (2021)

Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC
por: Walia, Anushka, et al.
Publicado: (2023)

“Age matters”—German claims data indicate disparities in lung cancer care between elderly and young patients
por: Walter, Julia, et al.
Publicado: (2019)

Daily Chronic Intermittent Hypobaric Hypoxia Does Not Induce Chronic Increase in Pulmonary Arterial Pressure Assessed by Echocardiography
por: Götschke, Jeremias, et al.
Publicado: (2018)

Adjuvant TKI treatment of EGFR-mutant lung cancer—already ripe for decision?
por: Kauffmann-Guerrero, Diego
Publicado: (2020)

Association of Planning Target Volume with Patient Outcome in Inoperable Stage III NSCLC Treated with Chemoradiotherapy: A Comprehensive Single-Center Analysis
por: Karin, Monika, et al.
Publicado: (2020)

Alterations in the chondrocyte surfaceome in response to pro-inflammatory cytokines
por: Jeremiasse, Bernadette, et al.
Publicado: (2020)

Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients
por: Taugner, Julian, et al.
Publicado: (2021)

The Strategies and Mechanisms of Immune Checkpoint Inhibitors for Brain Metastases in NSCLC
por: Li, Ji, et al.
Publicado: (2022)

Efficacy of docetaxel plus ramucirumab as palliative second-line therapy following first-line chemotherapy plus immune-checkpoint-inhibitor combination treatment in patients with non-small cell lung cancer (NSCLC) UICC stage IV
por: Brueckl, Wolfgang M., et al.
Publicado: (2021)

Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines
por: Fara, Antonella, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6cbq1frvg9l74e68usjhk7p2pq